$5.70
2.40% yesterday
Nasdaq, Apr 03, 10:00 pm CET
ISIN
US92337C1045
Symbol
VSTM
Sector
Industry

Verastem, Inc. Target price 2025 - Analyst rating & recommendation

Verastem, Inc. Classifications & Recommendation:

Buy
100%

Verastem, Inc. Price Target

Target Price $12.86
Price $5.70
Potential
Number of Estimates 7
7 Analysts have issued a price target Verastem, Inc. 2026 . The average Verastem, Inc. target price is $12.86. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 7 analysts: 7 Analysts recommend Verastem, Inc. to buy, 0 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Verastem, Inc. stock has an average upside potential 2026 of . Most analysts recommend the Verastem, Inc. stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Million $ 10.00 26.18
161.83%
Net Margin -1,638.95% -319.09%
80.53%

7 Analysts have issued a sales forecast Verastem, Inc. 2025 . The average Verastem, Inc. sales estimate is

$26.2m
Unlock
. This is
161.83% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$83.5m 735.00%
Unlock
, the lowest is
$5.4m 45.72%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $10.0m
2025
$26.2m 161.83%
Unlock
2026
$83.8m 219.92%
Unlock
2027
$190m 126.47%
Unlock
2028
$315m 65.94%
Unlock
2029
$419m 33.11%
Unlock

7 Verastem, Inc. Analysts have issued a net profit forecast 2025. The average Verastem, Inc. net profit estimate is

$-83.6m
Unlock
. This is
46.54% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-30.0m 80.80%
Unlock
, the lowest is
$-124m 20.34%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $-164m 7.58%
2025
$-83.6m 49.02%
Unlock
2026
$-57.0m 31.84%
Unlock
2027
$-7.0m 87.73%
Unlock
2028
$45.1m 744.49%
Unlock
2029
$72.8m 61.62%
Unlock

Net Margin

2024 -1,638.95%
2025
-319.09% 80.53%
Unlock
2026
-67.98% 78.70%
Unlock
2027
-3.68% 94.59%
Unlock
2028
14.31% 488.86%
Unlock
2029
17.38% 21.45%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ -3.66 -1.87
7.58% 48.91%
P/E negative
EV/Sales 9.43

7 Analysts have issued a Verastem, Inc. forecast for earnings per share. The average Verastem, Inc. EPS is

$-1.87
Unlock
. This is
46.42% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$-0.67 80.80%
Unlock
, the lowest is
$-2.78 20.34%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $-3.66 7.58%
2025
$-1.87 48.91%
Unlock
2026
$-1.27 32.09%
Unlock
2027
$-0.16 87.40%
Unlock
2028
$1.01 731.25%
Unlock
2029
$1.63 61.39%
Unlock

P/E ratio

Current -1.63 43.60%
2025
-3.06 87.73%
Unlock
2026
-4.48 46.41%
Unlock
2027
-36.54 715.63%
Unlock
2028
5.67 115.52%
Unlock
2029
3.51 38.10%
Unlock

Based on analysts' sales estimates for 2025, the Verastem, Inc. stock is valued at an EV/Sales of

and an P/S ratio of
11.21
Unlock
.

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 24.69
2025
9.43 61.81%
Unlock
2026
2.95 68.74%
Unlock
2027
1.30 55.84%
Unlock
2028
0.78 39.74%
Unlock
2029
0.59 24.88%
Unlock

P/S ratio

Current
2025
11.21 61.81%
Unlock
2026
3.50 68.74%
Unlock
2027
1.55 55.84%
Unlock
2028
0.93 39.73%
Unlock
2029
0.70 24.87%
Unlock

Current Verastem, Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Guggenheim
Locked
Locked
Locked Mar 24 2025
HC Wainwright & Co.
Locked
Locked
Locked Mar 24 2025
RBC Capital
Locked
Locked
Locked Mar 21 2025
B. Riley Securities
Locked
Locked
Locked Jan 31 2025
Guggenheim
Locked
Locked
Locked Jan 24 2025
RBC Capital
Locked
Locked
Locked Jan 07 2025
HC Wainwright & Co.
Locked
Locked
Locked Dec 19 2024
Analyst Rating Date
Locked
Guggenheim:
Locked
Locked
Mar 24 2025
Locked
HC Wainwright & Co.:
Locked
Locked
Mar 24 2025
Locked
RBC Capital:
Locked
Locked
Mar 21 2025
Locked
B. Riley Securities:
Locked
Locked
Jan 31 2025
Locked
Guggenheim:
Locked
Locked
Jan 24 2025
Locked
RBC Capital:
Locked
Locked
Jan 07 2025
Locked
HC Wainwright & Co.:
Locked
Locked
Dec 19 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today